Clearwater Analytics (NYSE: CWAN) and Enfusion, Inc. (NYSE: ENFN) announced their entry into a definitive merger agreement.
DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company’s proposed merger ...
Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement for Clearwater to acquire ...
Analysts have been eager to weigh in on the Technology sector with new ratings on Clearwater Analytics Holdings (CWAN – Research Report) and ...
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...
Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.With the bid ...
They emphasized the significance of integrating Enfusion's technology, which is expected to enhance Clearwater's offerings and potentially drive future growth. Clearwater Analytics specializes in ...
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker ...
They emphasized the significance of integrating Enfusion's technology, which is expected to enhance Clearwater's offerings and potentially drive future growth. Clearwater Analytics specializes in ...